Haleon (NYSE:HLN) Earns Buy Rating from Analysts at HSBC

Analysts at HSBC initiated coverage on shares of Haleon (NYSE:HLN) in a report released on Wednesday, MarketBeat reports. The firm set a “buy” rating on the stock.

Separately, Argus reaffirmed a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Haleon currently has a consensus rating of “Moderate Buy”.

Haleon Stock Up 0.1 %

Haleon stock opened at $8.12 on Wednesday. Haleon has a twelve month low of $7.70 and a twelve month high of $9.05. The business has a fifty day moving average of $8.30 and a two-hundred day moving average of $8.29. The firm has a market cap of $37.08 billion, a P/E ratio of 29.00, a P/E/G ratio of 2.12 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53.

Hedge Funds Weigh In On Haleon

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Ironwood Wealth Management LLC. purchased a new stake in shares of Haleon in the third quarter valued at approximately $70,000. Tower Research Capital LLC TRC purchased a new stake in Haleon in the 3rd quarter valued at $115,000. Credit Suisse AG acquired a new stake in shares of Haleon in the 3rd quarter worth $76,000. Guggenheim Capital LLC purchased a new position in shares of Haleon during the 3rd quarter worth $119,000. Finally, BlackRock Inc. acquired a new position in shares of Haleon during the 3rd quarter valued at about $10,366,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.